These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 26517583)

  • 21. A gonadotropin-releasing hormone agonist model demonstrates that nocturnal hot flashes interrupt objective sleep.
    Joffe H; Crawford S; Economou N; Kim S; Regan S; Hall JE; White D
    Sleep; 2013 Dec; 36(12):1977-85. PubMed ID: 24293774
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Depression is associated with worse objectively and subjectively measured sleep, but not more frequent awakenings, in women with vasomotor symptoms.
    Joffe H; Soares CN; Thurston RC; White DP; Cohen LS; Hall JE
    Menopause; 2009; 16(4):671-9. PubMed ID: 19197217
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Real-world evaluation of treatment utilization by women experiencing vasomotor symptoms associated with menopause in the United States and Europe: Findings from the REALISE study.
    Kingsberg S; Banks V; Caetano C; Janssenswillen C; Moeller C; Schoof N; Harvey M; Scott M; Nappi RE
    Maturitas; 2024 Nov; 189():108096. PubMed ID: 39208496
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design and methods of a multi-site, multi-behavioral treatment trial for menopausal symptoms: the MsFLASH experience.
    Sternfeld B; LaCroix A; Caan BJ; Dunn AL; Newton KM; Reed SD; Guthrie KA; Booth-LaForce C; Sherman KJ; Cohen L; Freeman MP; Carpenter JS; Hunt JR; Roberts M; Ensrud KE
    Contemp Clin Trials; 2013 May; 35(1):25-34. PubMed ID: 23462342
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of oral versus transdermal menopausal hormone treatments on self-reported sleep domains and their association with vasomotor symptoms in recently menopausal women enrolled in the Kronos Early Estrogen Prevention Study (KEEPS).
    Cintron D; Lahr BD; Bailey KR; Santoro N; Lloyd R; Manson JE; Neal-Perry G; Pal L; Taylor HS; Wharton W; Naftolin F; Harman SM; Miller VM
    Menopause; 2018 Feb; 25(2):145-153. PubMed ID: 28832429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vasomotor Symptoms and Accelerated Epigenetic Aging in the Women's Health Initiative (WHI).
    Thurston RC; Carroll JE; Levine M; Chang Y; Crandall C; Manson JE; Pal L; Hou L; Shadyab AH; Horvath S
    J Clin Endocrinol Metab; 2020 Apr; 105(4):1221-7. PubMed ID: 32080740
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The association of depression status with menopause symptoms among rural midlife women in China.
    Zang H; He L; Chen Y; Ge J; Yao Y
    Afr Health Sci; 2016 Mar; 16(1):97-104. PubMed ID: 27358619
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of bothersome symptoms during the late reproductive stage and menopausal transition: observations from the Women Living Better Survey.
    Woods NF; Coslov N; Richardson MK
    Menopause; 2023 Jan; 30(1):45-55. PubMed ID: 36576442
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methods for the design of vasomotor symptom trials: the menopausal strategies: finding lasting answers to symptoms and health network.
    Newton KM; Carpenter JS; Guthrie KA; Anderson GL; Caan B; Cohen LS; Ensrud KE; Freeman EW; Joffe H; Sternfeld B; Reed SD; Sherman S; Sammel MD; Kroenke K; Larson JC; Lacroix AZ
    Menopause; 2014 Jan; 21(1):45-58. PubMed ID: 23760428
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improving vasomotor symptoms; psychological symptoms; and health-related quality of life in peri- or post-menopausal women through yoga: An umbrella systematic review and meta-analysis.
    Shepherd-Banigan M; Goldstein KM; Coeytaux RR; McDuffie JR; Goode AP; Kosinski AS; Van Noord MG; Befus D; Adam S; Masilamani V; Nagi A; Williams JW
    Complement Ther Med; 2017 Oct; 34():156-164. PubMed ID: 28917368
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vasomotor and sexual symptoms in older Australian women: a cross-sectional study.
    Zeleke BM; Bell RJ; Billah B; Davis SR
    Fertil Steril; 2016 Jan; 105(1):149-55.e1. PubMed ID: 26450529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of sleep disorders in the menopausal transition.
    Schaedel Z; Holloway D; Bruce D; Rymer J
    Post Reprod Health; 2021 Dec; 27(4):209-214. PubMed ID: 34748453
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of pharmacologic and nonpharmacologic interventions on menopause-related quality of life: a pooled analysis of individual participant data from four MsFLASH trials.
    Diem SJ; LaCroix AZ; Reed SD; Larson JC; Newton KM; Ensrud KE; Woods NF; Guthrie KA
    Menopause; 2020 Oct; 27(10):1126-1136. PubMed ID: 32701665
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Yoga of Awareness program for menopausal symptoms in breast cancer survivors: results from a randomized trial.
    Carson JW; Carson KM; Porter LS; Keefe FJ; Seewaldt VL
    Support Care Cancer; 2009 Oct; 17(10):1301-9. PubMed ID: 19214594
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Three alternative ways to treat VMS failed.
    Pines A
    Climacteric; 2014 Aug; 17(4):512-3. PubMed ID: 25147889
    [No Abstract]   [Full Text] [Related]  

  • 36. A large multinational study of vasomotor symptom prevalence, duration, and impact on quality of life in middle-aged women.
    Blümel JE; Chedraui P; Baron G; Belzares E; Bencosme A; Calle A; Danckers L; Espinoza MT; Flores D; Gomez G; Hernandez-Bueno JA; Izaguirre H; Leon-Leon P; Lima S; Mezones-Holguin E; Monterrosa A; Mostajo D; Navarro D; Ojeda E; Onatra W; Royer M; Soto E; Tserotas K; Vallejo S;
    Menopause; 2011 Jul; 18(7):778-85. PubMed ID: 21407137
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hot flashes and estrogen therapy do not influence cognition in early menopausal women.
    LeBlanc ES; Neiss MB; Carello PE; Samuels MH; Janowsky JS
    Menopause; 2007; 14(2):191-202. PubMed ID: 17194963
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of menopausal vasomotor symptom severity with sleep and work impairments: a US survey.
    DePree B; Shiozawa A; King D; Schild A; Zhou M; Yang H; Mancuso S
    Menopause; 2023 Sep; 30(9):887-897. PubMed ID: 37625086
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of forehead cooling and supportive care on menopause-related sleep difficulties, hot flashes and menopausal symptoms: a pilot study.
    Baker FC; de Zambotti M; Chiappetta L; Nofzinger EA
    Behav Sleep Med; 2021; 19(5):615-628. PubMed ID: 33040586
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Menopausal Symptoms and Sleep Quality in Women Aged 40-65 Years.
    Song Z; Jiang R; Li C; Jin F; Tao M
    Biomed Res Int; 2022; 2022():2560053. PubMed ID: 35983252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.